Cardiologists are more often confronted with older (> 60 years) cardiovascular disease
(CVD) patients. These patients have particular needs in clinical care because, for example …

Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …

Aims We sought to investigate the prognostic impact of co-morbid burden as defined by the
Charlson Co-morbidity Index (CCI) in patients with a range of prevalent cardiovascular …

There is an increasing proportion of the general population surviving to old age with
significant chronic disease, multi-morbidity, and disability. The prevalence of pre-frail state …

Background Implantable cardioverter-defibrillator (ICD) therapy is recommended to reduce
mortality risk in patients with heart failure with reduced ejection fraction (HFrEF). Frailty is …

The age of patients presenting with complex arrhythmias is increasing. Frailty is a
multifaceted syndrome characterized by an increased vulnerability to stressors and a …

The Guidelines for the Pharmacological Treatment of Arrhythmias were first published in
2004, followed by the 2009 revision, 1 the 2013 revision of the Guidelines for the …

Mechanisms of aging predispose to cardiovascular disease (CVD), as well as to aggregate
health challenges. For older adults, CVD is likely to exist in combination with comorbid …

OBJECTIVES To determine whether the number of medications taken by adults with heart
failure (HF) and impairment in activities of daily living (ADL)—a subpopulation in whom the …

Heart failure (HF) is a devastating condition characterized by poor quality of life, numerous
complications, high rate of readmission and increased mortality. HF is the most common …